Table 6. The cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in patients < 30 years.
| Score | Classification | Cut-offs | Sensitivity, % | Specificity,% | PPV,% | NPV, % |
|---|---|---|---|---|---|---|
| APRI | Significant fibrosis | 0.2* | 94 | 15 | 21 | 91 |
| 1.0** | 18 | 91 | 31 | 83 | ||
| Cirrhosis | 0.3* | 91 | 16 | 5 | 98 | |
| 1.2** | 10 | 90 | 4 | 96 | ||
| FIB-4 | Significant fibrosis | 0.5* | 90 | 15 | 20 | 86 |
| 1.2** | 20 | 90 | 32 | 83 | ||
| Cirrhosis | 0.8* | 91 | 14 | 5 | 97 | |
| 1.4** | 10 | 92 | 5 | 96 |
APRI, aspartate transaminase to platelet ratio index; FIB-4, fibrosis index based on the 4 factors; PPV, positive predictive value; NPV, negative predictive value; Cut-offs* were established by obtaining a sensitivity of at least 90%; Cut-offs** were established by obtaining a specificity of at least 90%.